What the disciplines produce, together.

Intellicore Sentinel

2025 — present

In production

A multi-tenant AI voice platform that answers the calls a business would otherwise miss.

Intellicore Sentinel turns the missed call — the most expensive silence in a service business — into a handled conversation. It answers, understands, schedules, and routes, with a voice tuned to be near-indistinguishable from a human operator.

I architected the platform end to end: multi-tenant data isolation, telephony and voice orchestration, billing, and the operational tooling that keeps it observable in production. It is the current commercial flagship of Intellicore LLC.

Built with Stephen Gaon (CEO, New York) at Intellicore LLC, Wyoming.

Aviation Biofuel from Hemp Oil

Multi-year R&D

Validated at independent labs

A green Jet A-1 fuel refined from hemp-seed oil, through an advanced fatty-acid hydrotreatment chain.

Starting from 100% hemp-seed oil and a HEFA process — molybdenum and platinum catalysts, ~280 °C, ~2,800 PSI of pure hydrogen — I produced long-chain hydrocarbons, then carried them through deoxygenation, vacuum and fractional distillation.

The fractional column separates the phases cleanly: gasoline, diesel, and most importantly up to 75% yield of Jet A-1 aviation fuel. Parts of the testing were carried out at Cornell University, and in Colombia at Intertek and Proacem laboratories.

Bio-derived industrial chemistry. Some methods withheld as proprietary.

NeoSat

2026 — active

In development

Ultra-encrypted satellite communications for high-security environments.

NeoSat is an Intellicore program directed at mission-critical, defense-grade telecommunications: a satellite link hardened with custom encryption and physical isolation — shielded development boards, Mu-metal enclosures, and inter-board communication designed against interception.

It draws on the full stack at once — RF and satellite hardware, materials engineering, applied cryptography, and security-first architecture. Described here only at a high level; identifiers and methods are withheld.

Telecommunications for mission-critical environments. Not weapons development.

Nanofluids & Pharmaceutical Conversion

Multi-year R&D

Pilot & production scale

Making oil-based and water-based molecules coexist, stable, in a single formulation — without emulsifiers.

Using high-pressure microfluidization up to 45,000 PSI, I collide molecules through shear and impact down to ~50-micron particle sizes, converting fluids into nanofluids that become fully soluble in aqueous media.

Paired with spray-dry conversion — turning viscous or liquid actives into pharmaceutical powders — this opens formulation routes across pharma, food, and dermocosmetics. The same rigor produced an anti-aging serum, formulated with last-generation actives and commercialized in Europe with its own automated packaging and logistics line.

Actives from DSM, Evonik, Stepan, and Dow, among others.

Biomedical Microchip

Ongoing

Built hardware

A complete vitals module the size of a fingernail.

A 1.5 × 1.5 cm system carrying its own microcomputer, sensor array, signal concentrator, algorithm processor, Bluetooth antenna, micro LiPo battery, and wireless charging — measuring heart rate, temperature, and blood-oxygen saturation.

It sits at the intersection of biology, electronics, and computation, fabricated on my own microscopy and microsoldering bench alongside 1 mm² nanocomputers on Nordic, Texas Instruments, and Maxim platforms.

Microelectronics for biomedical monitoring and intervention.